Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 036900/0158 | |
| Pages: | 13 |
| | Recorded: | 10/20/2015 | | |
Attorney Dkt #: | 96700/2153 |
Conveyance: | CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
6
|
|
Patent #:
|
|
Issue Dt:
|
10/30/2018
|
Application #:
|
14390113
|
Filing Dt:
|
10/02/2014
|
Publication #:
|
|
Pub Dt:
|
02/12/2015
| | | | |
Title:
|
METHOD OF ENHANCING THE EFFICACY OF ANTI-HEPATOCYTE GROWTH FACTOR RECEPTOR BREAST CANCER THERAPY BY ADMINISTERING AN INHIBITOR OF MENAINV
|
|
|
Patent #:
|
|
Issue Dt:
|
09/13/2016
|
Application #:
|
14396102
|
Filing Dt:
|
10/22/2014
|
Publication #:
|
|
Pub Dt:
|
05/07/2015
| | | | |
Title:
|
TRANSFERRIN RECEPTOR APTAMERS AND APTAMER-TARGETED DELIVERY
|
|
|
Patent #:
|
|
Issue Dt:
|
07/24/2018
|
Application #:
|
14399335
|
Filing Dt:
|
11/06/2014
|
Publication #:
|
|
Pub Dt:
|
05/28/2015
| | | | |
Title:
|
NANOPARTICLE DELIVERY VEHICLE FOR S-NITROSO-N-ACETYL CYSTEINE AND USES THEREOF
|
|
|
Patent #:
|
|
Issue Dt:
|
05/02/2017
|
Application #:
|
14399557
|
Filing Dt:
|
11/07/2014
|
Publication #:
|
|
Pub Dt:
|
05/21/2015
| | | | |
Title:
|
MYCOBACTERIUM TUBERCULOSIS DeltaESX-3 MUTANTS
|
|
|
Patent #:
|
|
Issue Dt:
|
03/08/2016
|
Application #:
|
14487221
|
Filing Dt:
|
09/16/2014
|
Publication #:
|
|
Pub Dt:
|
04/16/2015
| | | | |
Title:
|
FIDGETIN-LIKE 2 AS A TARGET TO ENHANCE WOUND HEALING
|
|
|
Patent #:
|
|
Issue Dt:
|
03/13/2018
|
Application #:
|
14546830
|
Filing Dt:
|
11/18/2014
|
Publication #:
|
|
Pub Dt:
|
07/09/2015
| | | | |
Title:
|
Lateral Flow Device for Diagnosing Microbial Infections
|
|
Assignee
|
|
|
1300 MORRIS PARK AVENUE |
BRONX, NEW YORK 10461 |
|
Correspondence name and address
|
|
AMSTER, ROTHSTEIN & EBENSTEIN LLP
|
|
90 PARK AVENUE
|
|
NEW YORK, NY 10016
|
Search Results as of:
05/23/2024 04:29 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|